Past Speakers
![]() | Brad St. Croix, Ph.D.Senior Scientist Mouse Cancer Genetics Program Wednesday, June 26, 2024 | 12:00 PM (EST)Engineering antibody-drug conjugates with enhanced cancer eradicating capability |
Michael Aregger, Ph.D.Stadtman Investigator Molecular Targets Program Wednesday, June 12, 2024 | 12:00 PM (EST)Interrogating Genetic Interactions & Regulators of Metabolic Plasticity in Cancer Cells | |
![]() | Barbara K. Felber, Ph.D.Senior Investigator Vaccine Branch Wednesday, May 29, 2024 | 12:00 PM (EST)Nanoparticles, Biomarkers and Vaccines |
![]() | Deborah K. Morrison, Ph.D.Chief Laboratory of Cell and Developmental Signaling Wednesday, May 15, 2024 | 12:00 PM (EST)Understanding RAF Kinase Regulation: The Details DO Matter! |
![]() | David A. Wink Jr., Ph.D.Deputy Chief Cancer Innovation Laboratory Wednesday, May 8, 2024 | 12:00 PM (EST)NOS2 and COX2 Spatial Orientation with T-effector cells drive metastasis, cancer stemness and immunosuppression in ER- breast cancer leading to poor outcome |
![]() | Eric O. Freed, Ph.D.Director HIV Dynamics and Replication Program Wednesday, April 17, 2024 | 12:00 PM (EST)New advances in the study of HIV-1 assembly, maturation, and drug resistance |
![]() | Mark B. Lewandoski, Ph.D.Director Molecular Targets Program Wednesday, April 3, 2024 | 12:00 PM (EST)The myriad functions of FGF signaling in vertebrate mesoderm induction and axis extension |
![]() | Barry R. O'Keefe, Ph.D.Senior Investigator Cancer and Developmental Biology Laboratory Wednesday, March 27, 2024 | 12:00 PM (EST)Recent Developments in Natural Product Research |
![]() | Erin L. Davies, Ph.D.Stadtman Investigator Cancer and Developmental Biology Laboratory Wednesday, March 13, 2024 | 12:00 PM (EST)New invertebrate models for the study of adult stem cell-driven regeneration |
![]() | Zoë Weaver Ohler, Ph.D.Principal Scientist, Preclinical Evaluation Team Leader Center for Advanced Preclinical Research FNLCR Wednesday, February 28, 2024 | 12:00 PM (EST)TBA. |
![]() | Lino Tessarollo, Ph.D.Director Mouse Cancer Genetics Program Wednesday, March 6, 2024 | 12:00 PM (EST)Dissection of Neurotrophins function in Physiological and Pathological Conditions |
![]() | Vineet KewalRamani, Ph.D.Head Model Development Section Cancer Innovation Laboratory Wednesday, February 21, 2024 | 12:00 PM (EST)Shot to the heart: HIV trafficking to the cell nucleus. |
![]() | Raj Chari, Ph.D.Director Genome Modification Core Wednesday, February 14, 2024 | 12:00 PM (EST)Application of Genome Engineering Technologies in Cancer |
![]() | Sandra Wolin, M.D., Ph.DHead, Section on Noncoding RNAS and RNPS Wednesday, February 7, 2024 | 12:00 PM (EST)Dealing with Difficult RNA. |
![]() | Vinay Pathak, Ph.D.Head, Viral Mutation Section HIV Dynamics and Replication Program Wednesday, January 31, 2024 | 12:00 PM (EST)HIV-1 uncoating and nuclear import. |
![]() | Marc Nicklaus, Ph.D.Senior Scientist Chemical Biology Laboratory Wednesday, January 24, 2024 | 12:00 PM (EST)Synthetically Accessible Virtual Inventory (SAVI): On the way to trillions of molecules |
![]() | Kedar Narayan, Ph.D.Group Leader, Volume EM Group Wednesday, January 17, 2024 | 12:00 PM (EST)TBA. |
![]() | Euna Yoo, Ph.D.Stadtman Investigator Chemical Biology Laboratory Head, Chemical Immunology Section Wednesday, January 10, 2024 | 12:00 PM (EST)Dissecting immunomodulatory protease function using activity-based protein profiling and covalent ligand screening. |
![]() | Terry Yamaguchi, Ph.D.Head, Cell Signaling in Vertebrate Development Section Wednesday, December 13, 2023 | 12:00 PM (EST)TBA |
Stephen Anderson, Ph.D.Senior Investigator Cancer Innovation Laboratory Head, Molecular Immunology Section Wednesday, November 29, 2023 | 12:00 PM (EST)You “GATA” have switches to differentiate. | |
![]() | Allan Weissman, M.D.Senior Investigator. Cancer Innovation Laboratory Head, Protein Homeostasis and Signaling Section Wednesday, November 15, 2023 | 12:00 PM (EST)Insights into Ubiquitinating Ligases and a SARS-CoV-2 Protease from Endoplasmic Reticulum-Associated Degradation. |
Yinling Hu, Ph.DHead, Inflammation and tumorigenesis Section Cancer Innovation Laboratory Wednesday, October 25, 2023 | 12:00 PM (EST)Opportunistic Candida albicans and Cladosporium Target EGFR Family Members, Tweak Innate Immune Responses, and Promote Carcinogenesis. | |
Wei-Shau Hu, Ph.DDeputy Director Head, Viral Recomination Section HIV DRP Wednesday, October 18, 2023 | 12:00 PM (EST)The Regulation of HIV-1 RNA functions: it’s G-rated | |
Andy Stephen, Ph.D.Group Lead RAS Biochemistry and Biophysics Wednesday, October 11, 2023 | 12:00 PM (EST)Activation of RAF1 kinase by RAS proteins at the plasma membrane. | |
Scott Durum, Ph.D.Head, Cytokines, and Immunity Section Cancer Innovation Laboratory Wednesday, October 4, 2023 | 12:00 PM (EST)Role of the IL-7 pathway in acute lymphoblastic leukemia. | |
Daniel McVicar, Ph.D.Deputy Director, Center for Cancer Research Wednesday, September 20, 2023 | 12:00 PM (EST)Metabolic Adaptations of Macrophages in Inflammation, Cancer, and Metabolic Disease | |
Shyam Sharan, Ph.DDeputy Director, Senior Investigator, Head, Genetics of Cancer Susceptibility Section, Director, Center for Advanced Preclinical Research Wednesday, July 26, 2023 | 12:00 PM (EST)Making CRISPR sense of BRCA2 missense mutations using a high throughput functional assay | |
Mikhail Kashlev, Ph.DDeputy Chief, Senior Investigator, Head, Wednesday, June 21, 2023 | 12:00 PM (EST)
| |
Chengkai Dai, Ph.DStadtman Investigator Wednesday, June 14, 2023 | 12:00 PM (EST)A Powerful Enabler of Oncogenesis: Implications of HSF1 in Proteomic Instability and Non-Oncogene Addiction of Cancer | |
Gregory Del Prete, Ph.DViral Persistence Section Wednesday, June 7, 2023 | 12:00 PM (EST)Development and Use of Simian-Tropic HIV-1: | |
John Brognard, Ph.DHead, Signaling Networks in Cancer Section Wednesday, May 24, 2023 | 12:00 PM (EST)Cancers of Unmet Need: New Targets, New Drugs, and the Creation of a Biotech Startup | |
Alexander Wlodawer, Ph.DHead, Protein Structure Section IN PERSON ONLY - NCI Frederick Auditorium Wednesday, May 17, 2023 | 12:00 PM (EST)Many secrets of L-asparaginase, the oldest protein-based cancer drug | |
Peter F. Johnson, Ph.DHead, Eukaryotic Transcriptional Regulation Section Wednesday, May 10, 2023 | 12:00 PM (EST)Novel features of oncogenic signal transduction involving mRNA localization and signaling endosomes | |
| Matthew T. Wolf, Ph.DStadtman Investigator Wednesday, May 3, 2023 | 12:00 PM (EST)
|
| Kylie Walters, Ph.DHead, Protein Processing Section IN PERSON ONLY - NCI Frederick AuditoriumWednesday, March 29, 2023 | 12:00 PM (EST)A Tale of Two Proteasome Substrate Receptors: |
Ping Zhang, Ph.D.Head, Kinase Complex Section Wednesday, March 22, 2023 |12:00 PM (EST) Revealing Molecular Assemblies of Kinase Signaling Complexes: ConnecKng Structure and Mechanism | |
Kathrin Muegge, M.D.Head, Epigenetics Section Wednesday, March 15, 2023 |12:00 PM (EST) The role of the chromatin remodeler LSH in the ICF4 syndrome | |
| Professor Yifat Merbl, Ph.D.Principal Investigator, The Merbl Laboratory Wednesday, March 8, 2023 |12:00 PM (EST) Novel insight into tumor immunogenicity through the lens of the epiProteome |
| Xinhua Ji, Ph.D.Head, Biomolecular Structure Section Wednesday, February 18, 2023 |12:00 PM (EST) Structural view of dsRNA processing by RNase III enzymes: Sequence specificity, ruler-based mechanism, and cleavage site assembly |
| Alex Compton, Ph.D.Head, Antiviral Immunity and Resistance Section Wednesday, February 8, 2023 |12:00 PM (EST) Mechanisms of cell-intrinsic antiviral immunity |
Nadya Tarasova, Ph.D.Synthetic Biologics Facility Wednesday, December 14, 2022 |12:00 PM (EST) Moving from computer-aided to computer-driven molecular discovery | |
Frank Maldarelli, M.D., Ph.D.Wednesday, November 30, 2022 |12:00 PM (EST) HIV Persistence in Anatomic Compartments During Antiretroviral Therapy: A View From the Fridge | |
Terrence R. Burke Jr., Ph.D.Bioorganic Chemistry Section Wednesday, November 16, 2022 |12:00 PM (EST) Viewing HIV-1 Integrase Through a Chemistry Lens | |
| Susan Mackem, M.D., Ph.D.Regulation of Vertebrate Morphogenesis Section Wednesday, November 2, 2022 |12:00 PM (EST) Balancing robustness and control: why Shh is so highly dynamic in the limb and relevance for proliferation |
John Beutler, Ph.D.Head, Chemical Diversity Development Section Hunting bioactive natural products in Kazakhstan | |
John J. Schneekloth, Jr., Ph.D.Head, Chemical Genetics Section Developing the Tools to Target RNA with Small Molecules | |
Stephen Lockett, Ph.D.Optical Microscopy and Analysis Laboratory NCI-Frederick. Understanding Immune Suppression and Invasion in Tumors | |